Session 3: Immunology and the Tumor Microenvironment

Co-Chair(s)

• NC

  Nicholas Chiorazzi, MD

  Professor
  The Feinstein Institutes for Medical Research, Northwell Health System
  New York, New York, United States
• 

  Martina Seiffert, PhD

  Group Leader, Division of Molecular Genetics
  German Cancer Research Center
  Heidelberg, Germany

Presentations:

• 13:55 - 14:15 CEST

  Beyond Adhesion: Integrin Crosstalk with the BCR in CLL
  

  Speaker: Tanja Hartmann, PhD – Medical Center University Freiburg, Head Research and Clinical Research Coordination, Comprehensive Cancer Center Freiburg
• 14:15 - 14:35 CEST

  Understanding the Role and Targeting the Non-Lymphoid Elements in the Tumor Microenvironment
  

  Speaker: Alan G. Ramsay, PhD – Lymphoma Immunology Group, Kings College London
• 14:35 - 14:55 CEST

  Extracellular Vesicles in CLL
  

  Speaker: Etienne Moussay, PhD – Luxembourg Institute of Health
• 14:55 - 15:10 CEST

  Panel Discussion With Interactivity and Audience Q&A
• 15:10 - 15:15 CEST

  IFNγ/IL21-JAK-STAT1 Signaling Axis Drives T-Cell–Mediated CLL Proliferation and Venetoclax Resistance
  

  Primary Author / Presenter: Miroslav Boudny, PhD – Dept of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Rep.; CEITEC, Masaryk University
• 15:15 - 15:20 CEST

  Early effects of venetoclax monotherapy on immune cells in patients with chronic lymphocytic leukemia
  

  Primary Author / Presenter: Olina Lind, MSc – Department of Oncology-Pathology, Karolinska Institutet